Conversely, the activation of survival pathways, such as PI3K/Akt and MAPK/ERK [339, 340], or the expression of stem cell markers like CD44 and aldehyde dehydrogenase 1, may imply tumor relapse and progression [341, 342]. The gene discussed is AKT1; the disease is neoplasm.